Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚น45.70 B
Marketcap
โ‚น125.77
Share price
-1.41%
Change (1 day)
128.49%
Change (1 year)

Revenue for Lexicon Pharmaceuticals (LXRX)

Revenue in 2025 (TTM): โ‚น6.11 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น6.36 Billion. In 2024 the company made a revenue of โ‚น2.66 Billion an increase over the revenue in the year 2023 that were of โ‚น0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lexicon Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น6.11 B129.53%
2024 โ‚น2.66 B2557.96%
2023 โ‚น0.10 B772.13%
2022 โ‚น11.5 M-48.14%
2021 โ‚น22.18 M-98.74%
2020 โ‚น1.75 B-92.36%
2019 โ‚น22.96 B417.02%
2018 โ‚น4.44 B-22.98%
2017 โ‚น5.76 B1.85%
2016 โ‚น5.66 B-34.45%
2015 โ‚น8.64 B496.51%
2014 โ‚น1.44 B955.14%
2013 โ‚น0.13 B130.23%
2012 โ‚น59.62 M-39.04%
2011 โ‚น97.81 M-55.53%
2010 โ‚น0.21 B-55.7%
2009 โ‚น0.49 B-68.04%
2008 โ‚น1.55 B-21.02%
2007 โ‚น1.96 B-39%
2006 โ‚น3.22 B-5.33%
2005 โ‚น3.40 B27.37%
2004 โ‚น2.67 B37.09%
2003 โ‚น1.95 B15.55%
2002 โ‚น1.68 B-88.55%
2001 โ‚น14.74 B2085%
2000 โ‚น0.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.08 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น1.279 T 20,005.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น56.65 B 789.87%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น277.95 B 4,266.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.928 T 61,616.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น27.29 B 328.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น385.21 B 5,951.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น22.56 B 254.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น19.21 B 201.90%๐Ÿ‡บ๐Ÿ‡ธ USA